Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling

Fig. 2

CCR2 show greater expression in PBMC from mild COVID-19 patients. RNA of PBMCs from severe COVID-19 patients (n = 10), mild COVID-19 patients (n = 20), and healthy controls (n = 10) was reverse transcribed into cDNA, and then RT-qPCR was performed to quantify chemokine receptor and GAPDH levels. a Expression levels of CCR2 is higher in PBMCs from mild COVID-19 patients. b CXCR2 and c CXCR3 levels did not differ between COVID-19 patients and healthy controls. **P < 0.01

Back to article page

Virology Journal

ISSN: 1743-422X